Saturday 17 October 2026
Export MLAB’s income statement to Excel — free account
Mesa Laboratories, Inc.
MLAB Technology Scientific & Technical Instruments
Mesa Laboratories, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $249.1 million, up 3.38% from fiscal 2025. In the quarter to June 2026, revenue grew 1.00%, EPS fell 42.5%, free cash flow grew 1,503.7% and total debt rose 70.6%, each against the same quarter a year earlier. Dividend growth for ten consecutive years; insiders bought in the last twelve months.
122.48
5.26
−4.12%
Follow MLAB
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 2.66% | 3.88% | 2.18% | (0.92%) |
+8 more TTM periods Free account |
|
Piotroski F-Score |
7 | 7 | 6 | 5 | |
| 1.12% | 1.56% | 0.86% | (0.36%) | ||
ROIC |
4.67% | 3.72% | 3.33% | 2.82% | |
Return on Tangible Assets |
6.35% | 8.95% | 4.51% | (1.94%) | |
Average Days of Receivables |
50.29 | 64.61 | 59.32 | 59.67 | |
Free Cash Flow per Share |
9.35 | 7.18 | 6.86 | 6.76 | |
Free Cash Flow |
52.87 | 39.58 | 37.94 | 37.24 | |
Capital Expenditures |
(2.80) | (3.25) | (3.59) | (3.67) | |
| Other line items | |||||
Cash ROIC |
14.59% | 10.85% | 9.94% | 9.96% | |
Accounts Receivable Turnover |
6.80 | 5.79 | 6.28 | 6.11 | |
Accounts Payable Turnover |
13.02 | 17.02 | 19.93 | 16.76 | |
Inventory Turnover |
3.23 | 3.51 | 3.40 | 3.23 | |
Average Days of Payables |
30.46 | 19.80 | 20.60 | 20.02 | |
Days of Inventory on Hand |
111.19 | 105.94 | 104.17 | 109.08 | |
Tax Rate |
(0.49) | (0.44) | (0.73) | (1.22) | |
Research and Development Expense of Revenue |
8.03% | 8.15% | 8.14% | 8.23% | |
Selling, General and Administrative Expense of Revenue |
47.18% | 47.95% | 47.30% | 47.79% | |
Share Based Compensation of Revenue |
6.55% | 7.17% | 5.74% | 5.74% | |
Interest Coverage |
2.07 | 1.73 | 1.53 | 1.36 | |
Operating CF/Net income |
11.60 | 6.38 | 11.12 | (26.02) | |
Depreciation/Fixed assets |
0.76 | 0.76 | 0.78 | 0.78 | |
Capex/Depreciation |
(0.12) | (0.14) | (0.15) | (0.15) | |
Revenue per Share |
44.14 | 45.18 | 44.75 | 44.49 | |
Operating CF per Share |
9.84 | 7.77 | 7.51 | 7.42 | |
Capex per Share |
(0.49) | (0.59) | (0.65) | (0.67) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.02 |
Columns are period end dates